Prevalence of the sleep apnea syndrome (SAS) in acromegaly population Source: Eur Respir J 2002; 20: Suppl. 38, 576s Year: 2002
Microalbuminuria in patients with sleep apnea syndrome (SAS), before and after CPAP use Source: Annual Congress 2008 - Metabolic and sex-related aspects of obstructive sleep apnoea Year: 2008
Sleep apnoea syndrome (SAS) is associated with bronchial inflammation Source: Eur Respir J 2003; 22: Suppl. 45, 567s Year: 2003
Psychological profile in sleep apnea (SAS) and in primary snorers (PS) Source: Eur Respir J 2002; 20: Suppl. 38, 452s Year: 2002
The profile of the smoker patient with sleep apnoea syndrome (SAS) in Romania Source: Eur Respir J 2002; 20: Suppl. 38, 328s Year: 2002
Impact of CPAP on automobile accidents in patients with sleep apnoea syndrome (SAS) Source: Eur Respir J 2001; 18: Suppl. 33, 16s Year: 2001
Is IGF-1 a marker of cardio-metabolic risk in sleep apnea syndrome (SAS)? Source: International Congress 2016 – Cardiovascular and metabolic pathophysiology and outcomes of obstructive sleep apnoea Year: 2016
Metabolic syndrome in obstructive sleep apnoea patients Source: Annual Congress 2007 - Sleep apnoea Year: 2007
Obstructive sleep apnoea syndrome (OSAS) and diabetes: influence of obesity Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008
Obstructive sleep apnoea (OSA) and hypothyroidism Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea Year: 2009
Masked hypertension and obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2006; 28: Suppl. 50, 416s Year: 2006
Transition from obstructive sleep apnea (OSA) to obesity hypoventilation syndrome (OHS) Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults I: questionnaires, epidemiology and sleep studies Year: 2015
Treatment of obstructive sleep apnoea syndrome (OSAS) with uvulo palatal flep (UPF) Source: Eur Respir J 2003; 22: Suppl. 45, 96s Year: 2003
Resources and delays in the diagnosis of sleep apnea and hypopnea syndrome Source: Eur Respir J 2007; 30: Suppl. 51, 329s Year: 2007
Obstructive sleep apnea syndrome (OSAS). Value of cardiovascular markers (CM) to detect arousals Source: Eur Respir J 2003; 22: Suppl. 45, 272s Year: 2003
Cost estimation of obstructive sleep apnea hypopnea syndrome (OSAHS) diagnosis in Greece Source: Annual Congress 2010 - Influence of delivery of care on outcome parameters: therapy is more than medication prescription Year: 2010
Impact of obstructive sleep apnoea (OSA) on glucose metabolism Source: Annual Congress 2007 - Cardiovascular and metabolic consequences of obstructive sleep apnoea: early changes, biomarkers and impact of treatment Year: 2007
Obstructive sleep apnea syndrome (OSA) and hypercoagulability – What is the impact of sole OSA in the absence of comorbities? Source: Annual Congress 2013 –Sleep disordered breathing in special situations I Year: 2013
Cortisol metabolism in obstructive sleep apnea (OSA) Source: Eur Respir J 2002; 20: Suppl. 38, 215s Year: 2002
Socioeconomic status and obstructive sleep apnea hypopnea syndrome (OSAHS) Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea Year: 2009